Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance

Atherosclerosis

Volumn 137, Issue SUPPL., 1998, Pages

  Laakso, Markku ^a   Lehto, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cerebrovascular disease; Coronary heart disease; Non insulin dependent diabetes; Peripheral vascular disease

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY RISK; DIABETES MELLITUS; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031781832     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00314-6     Document Type: Conference Paper

References (88)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987;3:463.
2. Goldberg RB. Lipid disorders in diabetes. Diabetes Care 1981;4:561.
3. Laakso M, Voutilainen E, Sarlund H, Aro A, Pyörälä K, Penttilä I. Serum lipids and lipoproteins in middle-aged non-insulin dependent diabetics. Atherosclerosis 1985;56:271-81.
4. Laakso M, Barrett-Connor E. Asymptomatic hyperglycaemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 1989;9:665.
5. Laakso M, Lehto S, Penttilä I, Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993;88:1421.
6. Abbud ZA, Shindler DM, Wilson AC, Kostis JB. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 1995;130:51.
7. Lehto S, Pyörälä K, Miettinen H, Rönnemaa T, Palomäki P, Tuomilehto J, Laakso M. Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1994;236:291.
8. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988;9:259.
9. Fava S, Azzopardi J, Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 1993;16:1615.
10. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure:the Framingham study. Am J Cardiol 1974;34:29.
11. Barbash GI, White HD, Modan M, Van-de-Werf F. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol 1993;22:707.
12. Scheidt-Nave C, Barrett-Connor E, Wingard DL. Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin dependent diabetes mellitus in a defined population. Circulation 1990;81:899.
13. Lomuscio A, Castagnone M, Vergani D, Verzoni A, Beltrami A, Ravaglia R, Pozzoni L. Clinical correlation between diabetic and non-diabetic patients with myocardial infarction. Acta Cardiol 1991;46:543.
14. Wilson PWF, Cupples LA, Kannel WP. Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 1991;121:586.
15. Laws A, Marcus EB, Grove JS, Curb JD. Lipids and lipoproteins as risk factors for coronary heart disease in men with abnormal glucose tolerance: the Honolulu Heart Program. J Intern Med 1993;234:471.
16. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151:1141.
17. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. J Am Med Assoc 1979;241:2035.
18. Stamler J, Vaccaro O, Neaton J, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434.
19. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 1988;11:449.
20. Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K. Does NIDDM increase the risk for coronary heart disease similarly in low and high risk populations? Diabetologia 1995;38:487.
21. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960.
22. Bell DS. Stroke in the diabetic patient. Diabetes Care 1994;17:213.
23. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol 1993;3:493.
24. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke. The Honolulu Heart Program. J Am Med Assoc 1987;257:949.
25. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996;27:63.
26. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 1994;25:1157.
27. Melton LJ, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 1980;3:650.
28. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication and risk of cardiovascular events. The Framingham Study. Diabetes 1989;38:504.
29. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyörälä K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 1993;16:16.
30. Nelson RG, Gohdes DM, Everhart JE, Hartner JA, Zwemer FL, Pettitt DJ, Knowler WC. Lower-extremity amputations in NIDDM. 12-year follow-up study in Pima Indians. Diabetes Care 1988;11:8.
31. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1996;19:607.
32. Lindbom Å. Arteriosclerosis and arterial thrombosis in the lower limb: a roentgenological study (Academic dissertation). Stockholm: University of Stockholm, 1950.
33. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia 1988;31:16.
34. Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vase Biol 1996;16:978.
35. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. New Engl J Med 1984;311:953.
36. Uusitupa M, Siitonen O, Voutilainen E, Aro A, Hersio K, Pyörälä K, Penttilä I, Ehnholm C. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (Type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 1986;9:17.
37. Mykkänen L, Laakso M, Pyörälä K. Asymptomatic hyperglycemia and atherosclerotic vascular disease in the elderly. Diabetes Care 1992;15:1020.
38. Sarlund H, Pyörälä K, Penttilä I, Laakso M. Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. Arterioscler Thromb 1992;12:657.
39. Capaldo B, Tutino L, Patti L, Vaccaro O, Rivellese A, Riccardi G. Lipoprotein composition in individuals with impaired glucose tolerance. Diabetes Care 1983;6:575.
40. Laakso M, Pyörälä K. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes. Metabolism 1990;39:117.
41. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L. Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chronic Dis 1984;37:773.
42. Stewart MW, Laker MF, Dyer RG, Game F, Mitcheson J, Winocour PH, Alberti KGMM. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb 1993;13:1046.
43. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979;59:8.
44. Taskinen M-R. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992;41(2):12.
45. Barrett-Connor E, Criqui MH, Klauber MR, Holdbrook M. Diabetes and hypertension in a community of older adults. Am J Epidemiol 1981;113:276.
46. Swislocki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989;2:419.
47. West KM. Epidemiology of Diabetes and its Vascular Lesions. New York: Elsevier, 1978.
48. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990;132:501.
49. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body-fat distribution. Diabetes 1990;39:283-8.
50. Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non-insulin-dependent diabetic patients:relationship with plasma insulin. Thromb Haemost 1989;61:370.
51. van Gaal L, Steijaert M, Rillaerts E, De Leeuw I. The plurimetabolic syndrome and hemocoagulation system. In: Crepaldi V, Tiengo A, Manzato E, editors. Diabetes, obesity and hyperlipidemias. Amsterdam: Excerpta Medica, 1993, pp. 229-37.
52. Jarrett RJ, Shipley MJ. Mortality and associated risk factors in diabetics. Acta Endocrinol 1985;110(272):21.
53. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997;46:1354.
54. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. 5-Year incidence of the atherosclerotic vascular disease in relation to general risk factors, insulin level and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 1990;82:27.
55. Lee JS, Lu M, Lee VS, Russell D, Bahr C, Lee ET. Lower-extremity amputation. Incidence, risk factors and mortality in the Oklahoma Indian Diabetes Study. Diabetes 1993;42:876.
56. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8.
57. Laakso M. Epidemiology of diabetic dyslipidemia. Diabetes Rev 1995;3:409.
58. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556.
59. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, Ruckley CV. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared to ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331.
60. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med 1992; 117:97.
61. Wang S-L, Head J, Stevens L, Fuller JH, World Health Organization Multinational Study Group. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. Diabetes Care 1996;19:305.
62. Stokes J, Kannel WB, Wolf PA, Cupples LA, D-Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987;75:65.
63. Lavy S, Melamed E, Cahane E, Carmon A. Hypertension and diabetes as risk factors in stroke patients. Stroke 1973;4:751.
64. Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care 1995;18:509.
65. Palumbo PJ, O'Fallon WM, Osmundson PJ, Zimmerman BR, Langworthy AL, Kazmier FJ. Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive. Arch Intern Med 1991;151:717.
66. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968.
67. Fitzgerald AP, Jarrett RJ. Are conventional risk factors for mortality relevant in type 2 diabetes? Diabetic Med 1991;8:475.
68. Balkau B, Eschwege E, Papoz L, Richard JL, Claude JR, Warnet JM, Ducimetiere P. Risk factors for early death in non-insulin dependent diabetes and in men with known glucose tolerance status. Br Med J 1993;307:295.
69. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tiblin G. Abdominal adipose tissue distribution, obesity and risk of cardiovascualar disease and death: 13-year follow-up participants in the study of men born 1913, Br Med J 1984;288:1401.
70. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44:1303.
71. Mattock MB, Morrish NJ, Vilberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736.
72. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttilä I. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990;33:237.
73. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 1995;91:831.
74. Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers, New Engl J Med 1986:717.
75. Sasaki A, Horiuchi N, Hasegawa K, Uehara M. Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan. Diabetes Res Clin Pract 1995;27:77.
76. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjects. Stroke 1996;27:2033.
77. Stamler R, Stamler J. Asymptomatic hyperglycemia and coronary heart disease. A series of papers by the International Collaborative Group, based on studies on fifteen populations. J Chron Dis 1979;32:638.
78. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993;36:1175.
79. Andersson DKG. Diabetes mellitus in a defined population. A longitudinal study with special reference to early diagnosis, occurrence and mortality. Comprehensive summaries of Uppsala dissertations from the Faculty of Medicine. Stockholm, Almqvist and Wiksell International, 1994, vol. 462.
80. McCall AL. The impact of diabetes on the CNS. Diabetes 1992;41:557.
81. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258.
82. Humphrey ARG, Dowse GK, Thoma K, Zimmet PZ. Diabetes and non-traumatic lower extremity amputations. Diabetes Care 1996;19:710.
83. Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. New Engl J Med 1996;334:952.
84. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidology 1996;7:217.
85. Jarrett RJ, McCartney P, Keen H. The Bedford Study:Ten year mortality rates in newly diagnosed diabetics, bordeline diabetics and normoglycemic controls and risk indices for coronary heart disease in bordeline diabetics. Diabetologia 1982;22:79.
86. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis. A multifactorial disease. Circulation 1993;87(3):3.
87. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. New Engl J Med 1984;311:501.
88. Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New Engl J Med 1985;313:1557.